商业 · 2023/9/51 分钟阅读
Merck Sharp & Dohme LLC, et al.; Withdrawal of Approval of 35 New Drug Applications
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA or Agency) is withdrawing approval of 35 new drug applications (NDAs) from multiple applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.